Cerebral malaria

Douglas G Postels1, Thembi Katangwe-Chirwa2

  • 1Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi; Division of Neurology, Children's National Hospital/ George Washington University, 111 Michigan Avenue NW, Washington DC 20010, USA.

PubMed

Insights

Cerebral malaria, a severe Plasmodium falciparum infection, has high mortality and long-term neurological issues in children. Adjunctive therapies are still needed to improve outcomes and address care gaps in survivors.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Cerebral malaria is the most lethal Plasmodium falciparum complication.
  • It causes significant mortality and long-term neurological deficits in children.
  • Existing treatments lack adjunctive therapies to reduce mortality and morbidity.

Purpose of the Study:

  • To review the epidemiology, clinical features, and diagnostic considerations of cerebral malaria.
  • To outline optimal clinical care pathways and address neurological sequelae.
  • To identify existing care gaps in managing cerebral malaria and its complications.

Main Methods:

  • Review of epidemiological data.
  • Analysis of clinical features and diagnostic considerations.
  • Evaluation of neuroimaging (MRI), electroencephalogram (EEG), and transcranial Doppler (TCD) findings.

Main Results:

  • Cerebral malaria has a high mortality rate, especially in children.
  • Neurological, cognitive, and behavioral sequelae are common in survivors.
  • Advanced neuroimaging and electrophysiological studies offer insights into pathogenesis and outcomes.

Conclusions:

  • Optimal clinical care pathways are established, but adjunctive therapies are lacking.
  • Significant care gaps persist for survivors, particularly in rural settings.
  • Further research is needed to develop effective adjunctive treatments and improve long-term care.